[The results of using different forms of a Ginkgo biloba extract (EGb 761) in the combined treatment of patients with circulatory encephalopathy].
Studies made in 208 patients with discirculatory encephalopathy using clinical and neuropsychological tests, apparatus (REG, ECG, EEG, Doppler sonography) and laboratory (coagulogramme) methods showed the prescription of drug preparations from ginkgo extract to be a worth-while exercise likely to benefit the patient during different stages of his/her affection. Positive time-related course was recordable of change in elastic and tonic characteristics of vessels, of bioelectric brain activity, emotional and behavioral, cognitive and mnestic features. The above-mentioned drugs will, we believe, help in developing new options for the outpatient, hospital, and rehabilitative stage of managing a patient. Potentiation of the positive action of ginkgo preparations showed up when being combined with a complex of components of the tricarboxylic acid cycle.
Ivaniv
O P
OP
D000328:Adult; D002561:Cerebrovascular Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D004359:Drug Therapy, Combination; D005419:Flavonoids / Q000627:therapeutic use*; D020441:Ginkgo biloba / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D009483:Neuropsychological Tests; D009484:Neuropsychology; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use; D010946:Plants, Medicinal; D014665:Vasodilator Agents / Q000627:therapeutic use*; D000096983:Ginkgo Extract
D005419:Flavonoids; D018696:Neuroprotective Agents; D010936:Plant Extracts; D014665:Vasodilator Agents; C063170:Ginkgo biloba extract; D000096983:Ginkgo Extract